Advertisement

Topics

Cymbalta (duloxetine)

05:09 EST 16th December 2018 | BioPortfolio

Major depressive disorder, generalized anxiety disorder, management of diabetic peripheral neuropathic pain and fibromyalgia; management of chronic musculoskeletal pain due to chronic osteoarthritis pain and chronic low back pain.

2012 sales: $4.994 billion

Drug maker: Eli Lilly

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy Cymbalta (duloxetine) market research data and corporate reports here